Career Advice for Managers: Week of September 27, 2010

“My style was fire-and-brimstone but I realized that people respond more favorably to positive motivation.”

David Schlotterbeck, Chairman and CEO of CareFusion, a medical device company in San Diego


 

More Interviewing and Hiring Tips From the Executive Suite

In this week’s New York Times “Corner Office”, Aaron Levie, the 25 year old CEO of Box.net a Silicon Valley online file storage company had provided these valuable insights and tips about interviewing and hiring new employees. 

Q. Let’s talk about hiring.

A. One thing that’s really important is understanding what they’ve done in their career. Just walk me through how you got to where you are today. What are the factors that led to specific decisions — that can give you a level of insight into behavior and how they make decisions.

Energy and persistence are the two most important factors, in addition to just having a clean résumé where there’s nothing crazy going on.

Curiosity is another big thing and a way to identify who’s going to be energetic and have the right attitude.

Q. If you could ask a job candidate just a few questions, what would they be?

A. “What questions do you have for me?” That will help you see how they’re thinking about the challenges. A lot of times I’ll say, “When you’re thinking about Box as an opportunity, how do you compare it to other organizations? What do we have that you want to be a part of?” Getting them to articulate the values back to you about what kind of organization they want to be a part of can actually be very useful.

Although Mr Levie is only 25 years old, the things that he looks for in new hires and the type of questions that he asks during face-to-face (F2F) job interviews have stood the test of time!

For the complete interview, please visit.

Until next time

Good Luck and Good Job Hunting!!!!!!

 

AstraZeneca to Freeze Salaries of Its CEO and Other Executives

AstraZeneca today announced that its Chief Executive David Brennan will receive no increase to his base salary this year, as the drug maker continues a freeze for top executives imposed last year due to weak economic conditions.

Brennan's 2010 salary will remain at $1.4 million, the same level since 2008. However, Brennan’s overall compensation has been on the rise for the past few years. His total remuneration, which includes bonus, shares and other items, rose 5% to $4.9 million for 2009, versus $4.7 million for 2008, according to documents recently filed with the Securities and Exchange Commission.

AstraZeneca said the base-salary freeze for 2010 also applies to other senior executives whose responsibilities are unchanged. 

While it is laudable that the company is freezing the base salary of its executives, most of their annual compensation is derived from bonuses, stock grants and options and other perks and benefits. I am certain that the hundreds of thousands of pharmaceutical employees who lost their jobs over the past three years can sleep better at night knowing that pharmaceutical executives are finally feeling the pain and sharing the pain of a down economy.

Hat tip to Ed at Pharmalot!

Until next time…

Good Luck and Good Job Hunting!!!!!!!!!!

 

Fred Hassan Shares His Views on the Past, Present and Future of the Pharmaceutical Industry

I just received a phone call from UK-based Meettheboss.TV to give me advance notice of an interview that was conducted with Fred Hassan, the former CEO of Schering Plough, that will be shown tomorrow at the Meettheboss.TV website. Hassan stepped aside as CEO after Merck acquired Schering Plough for $41.1 billion late last year.

Mr Hassan is arguably one of the most respected and highly visible pharmaceutical executives in the industry. He sat down with Meettheboss.TV to share how he was able to turn around a dysfunctional and failing Schering Plough and restore its tarnished image.

“I joined a company in 1997 that was in great difficulty.  There has been a merger between a Swedish company and a U.S. company, and that merger had resulted in a lot of difficulties, I was brought in as a CEO from the outside to try to make this merger work.  I realized that the future growth product of this company has been compromised in a deal that had to be untangled.” Fred told Meettheboss.tv

In an uncharacteristically candid interview, Hassan also offers his personal insights and views on the challenges that the pharmaceutical industry faces in the future as traditional business models begin to change and new players enter the pharmaceutical industry space. 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

To watch the full interview, please visit Meettheboss.TV

Until next time....

Good Luck and Good Viewing!!!!!!!!